Stocks and Investing Stocks and Investing
Wed, June 28, 2023
Tue, June 27, 2023

Annabel Samimy Reiterated (CARA) at Strong Buy and Held Target at $28 on, Jun 27th, 2023


Published on 2024-10-28 04:32:25 - WOPRAI, Annabel Samimy
  Print publication without navigation


Annabel Samimy of Stifel, Reiterated "Cara Therapeutics, Inc." (CARA) at Strong Buy and Held Target at $28 on, Jun 27th, 2023.

Annabel has made no other calls on CARA in the last 4 months.



There are 6 other peers that have a rating on CARA. Out of the 6 peers that are also analyzing CARA, 0 agree with Annabel's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Annabel


  • Jason Gerberry of "B of A Securities" Maintained at Sell with Decreased Target to $4 on, Tuesday, May 16th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Tuesday, May 16th, 2023
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $15 on, Tuesday, May 16th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023
  • Daniel Wolle of "JP Morgan" Maintained at Buy with Decreased Target to $16 on, Tuesday, March 7th, 2023
  • David Amsellem of "Piper Sandler" Maintained at Buy with Decreased Target to $13 on, Tuesday, March 7th, 2023

Contributing Sources